Target intelligence / Profile preview

Sorcin pseudogene 1 (SRIP1)

Target: SRIP1
Molecular classification: Other (Pseudogene)

Overview

Sorcin pseudogene 1 (SRIP1) is a non-coding pseudogene related to the sorcin (SRI) gene. Pseudogenes are genomic DNA sequences similar to normal genes but typically do not encode functional proteins. There is no evidence that SRIP1 is transcribed, translated, or plays a functional role in cellular processes or disease. It is not considered a clinical or therapeutic target and does not contribute to known biological or pharmacological pathways[4][5].

Other names: SRIL

Beyond the preview

Go deeper on Sorcin pseudogene 1 (SRIP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorcin pseudogene 1 (SRIP1).

Explore the full profile